BSE
Your Result on : Company News Details
Emcure Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
544210
ISIN Demat
INE168P01015
Book Value (Rs)
216.4487187
NSE Symbol
EMCURE
Divident Yield %
0.15
Market Cap
(Rs In Cr.)
44,378
P/E (TTM)
46.29
EPS (TTM)
50.53
Face Value
(Rs)
10
Back
Board of Emcure Pharmaceuticals approves draft scheme of amalgamation
12-Oct-26   Hrs IST

The board of Emcure Pharmaceuticals at its meeting held on 12 October 2026 has approved the draft Composite Scheme of Amalgamation amongst Zuventus Healthcare and Emcutix Biopharmaceuticals (collectively referred to as the Transferor Companies) both being wholly owned subsidiaries of the Company with Emcure Pharmaceuticals (Transferee Company) and their respective shareholders and creditors pursuant to Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (Scheme).

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
BSE Delayed market data sourced at 5 minutes – www.bseindia.com
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)